• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Mydecine Innovations, NeuroPharm Sign Acquisition Agreement americanpharmaceuticalreview
    July 22, 2020
    Mydecine Innovations has entered into a definitive share exchange agreement for the acquisition of 100% of NeuroPharm, a Canadian-based developer of natural psychedelic-based treatments for mental health disorders in the Canadian and United States ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service